SCHEMBL11711871

SCHEMBL11711871

Nc1ccc(Sc2cccc(OCCCC3CCNC3)c2)cc1N

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.39
SLC6A4 P31645 4/20 0.39
SLC6A3 Q01959 1/20 0.39
ROCK1 Q13464 1/20 0.35
HTR2C P28335 1/20 0.35
HTR6 P50406 1/20 0.35
ITGB3 P05106 3/20 0.35
ITGA2B P08514 3/20 0.35
NPY1R P25929 7/20 0.35
DDB1 Q16531 1/20 0.34
CRBN Q96SW2 1/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
HTR3A P46098 1/20 0.33
KCNH2 Q12809 1/20 0.33
PRKCZ Q05513 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11720038 0.97 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ROCK1HTR2C
SCHEMBL11715754 0.94 EED (0.40) NPY1R
SCHEMBL11713762 0.90 ITGB3 (0.42) SLC6A2SLC6A4ROCK1ITGB3ITGA2B
SCHEMBL11717587 0.90 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3ITGB3ITGA2B
SCHEMBL11716427 0.87 ITGB3 (0.42) SLC6A2SLC6A4SLC6A3ITGB3ITGA2B
SCHEMBL2890073 0.84 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3ITGB3ITGA2B
SCHEMBL11719097 0.83 NPY1R (0.41) NPY1R
SCHEMBL11716570 0.83 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3ROCK1ITGB3
SCHEMBL11715796 0.82 SLC6A4 (0.36) SLC6A2SLC6A4SLC6A3HTR2CHTR6
SCHEMBL11715349 0.82 HTR2C (0.36) SLC6A2SLC6A4SLC6A3HTR2CHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4010272-A ANTHELMINTICALLY ACTIVE BASICALLY SUBSTITUTED 2-CARBALKOXY-AMINO-BENZIMIDAZOLYL-5(6)-PHENYL ETHERS AND -KETONES HOECHST AKTIENGESELLSCHAFT (DT) 1977-03-01 US disclosed